BATS:VIRS Pacer BioThreat Strategy ETF (VIRS) Price, Holdings, & News $40.02 0.00 (0.00%) As of 10/10/2024 Add Compare Share Share Stock Analysis Stock AnalysisDividendHoldingsBuy This Stock About Pacer BioThreat Strategy ETF (BATS:VIRS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VIRS alerts:Sign Up Key Stats Today's Range$40.00▼$40.0350-Day Range$40.03▼$40.0352-Week Range N/AVolume1,985 shsAverage VolumeN/AMarket Capitalization$4.00 millionAssets Under Management$4.00 millionDividend Yield0.82%Net Expense Ratio0.70%Aggregate RatingN/A ETF Overview The Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that is based on the LifeSci BioThreat Strategy index. The fund tracks a market-cap weighted index of US companies whose products or services address biological threats to human health. VIRS was launched on Jun 24, 2020 and is managed by Pacer. Read More Pacer BioThreat Strategy ETF ExpensesTypeVIRSTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.70%0.57%0.56%0.57%0.53%Other Expenses0.00%0.57%0.56%0.48%0.56%Total Expense0.70%0.74%0.76%0.71%0.73%Fee Waiver0.00%-0.76%-0.66%-0.46%-0.63%Net Expense0.70%0.60%0.63%0.64%0.60% Receive VIRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacer BioThreat Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address VIRS ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com VIRS ETF - Frequently Asked Questions How have VIRS shares performed this year? Pacer BioThreat Strategy ETF's stock was trading at $40.0250 at the beginning of 2025. Since then, VIRS stock has increased by 0.0% and is now trading at $40.0250. How do I buy shares of Pacer BioThreat Strategy ETF? Shares of VIRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pacer BioThreat Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pacer BioThreat Strategy ETF investors own include Enphase Energy (ENPH), iShares Global Clean Energy ETF (ICLN), Nuance Communications (NUAN), Align Technology (ALGN), Autodesk (ADSK), Analog Devices (ADI) and Adobe (ADBE). Fund Details IssuerPacer Financial Fund NamePacer BioThreat Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:VIRS Inception Date6/24/2020 Fund ManagerBruce Kavanaugh, Michael Mack WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci BioThreat Strategy Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionNorth America Number of Holdings1 Fund Statistics Assets Under Management$4.00 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorPacer Advisors, Inc. CustodianU.S. Bank, N.A. DistributorPacer Financial, Inc. Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Miscellaneous Outstanding Shares100,000Beta0.85 Creation Unit50,000 Creation Fee$250.00 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Top 3 VIRS HoldingsU.S. Bank Money Market Deposit AccountHolding Weight: 99.87%DEPOSITS WITH BROKER FOR SHORT POSITIONSHolding Weight: 0.10%US DOLLARSHolding Weight: 0.03%Full Holdings Details This page (BATS:VIRS) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | SponsoredTrump’s national nightmare is hereWhile the headlines focus on global conflicts, there’s a very different crisis brewing at home. Washington has...Porter & Company | SponsoredIt’s game over for Central BanksCentral banks are losing control. Inflation isn’t fixed, debt is exploding, and stocks have never looked more ...Golden Portfolio | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacer BioThreat Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacer BioThreat Strategy ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.